Drug General Information
Drug ID
D02ZPN
Former ID
DIB006616
Drug Name
NN-414
Synonyms
NNC-55-0414
Drug Type
Small molecular drug
Indication Type 1 diabetes [ICD9: 250; ICD10:E10] Phase 1 [521917]
Company
Novo Nordisk A/S
Structure
Download
2D MOL

3D MOL

Formula
C9H10ClN3O2S2
Canonical SMILES
S1(=O)(=O)c2c(cc(s2)Cl)NC(=N1)NC1(CC1)C
PubChem Compound ID
Target and Pathway
Target(s) Sulfonylurea receptor 1 Target Info Modulator
KEGG Pathway ABC transporters
Insulin secretion
Type II diabetes mellitus
Pathway Interaction Database FOXA2 and FOXA3 transcription factor networks
PathWhiz Pathway Muscle/Heart Contraction
Pancreas Function
Reactome ABC-family proteins mediated transport
Regulation of insulin secretion
WikiPathways Potassium Channels
Integration of energy metabolism
References
Ref 521917ClinicalTrials.gov (NCT00400283) A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.